Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Efstratios Maltezos |
| Publication date | September 1, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |